James M Frincke

Title: The Innovative Contributions of James M Frincke in Biotechnology

Introduction: James M Frincke, a distinguished inventor based in Solana Beach, California, has made significant contributions to the field of biotechnology through his innovative research and development. With a total of two patents to his name, Frincke's work primarily focuses on enhancing therapeutic compositions that leverage the power of antibodies and interferon for improved medical treatments.

Latest Patents: Frincke's latest patents reflect his commitment to advancing healthcare solutions. His first patent, titled "Interferon antibody therapeutic compositions having an extended serum," introduces a complex of alpha-interferon paired with a monoclonal antibody. This innovative composition ensures that the antiviral activity of alpha-interferon is maintained while substantially increasing its serum half-life compared to alpha-interferon administered alone. This breakthrough may significantly enhance the efficacy and duration of treatment for patients.

In addition, his second patent, "Non-covalent antibody-anthracycline immunocomplexes," reveals a composition that comprises a non-covalent immunocomplex of an anthracycline agent and a specifically selected antibody that binds to a target antigen. This invention aims to enhance the cytotoxicity of the anthracycline agent, facilitating its use as an anti-tumor agent in vivo and improving therapeutic outcomes for cancer patients.

Career Highlights: James M Frincke is currently associated with Hybritech Incorporated, where he contributes his extensive expertise in biopharmaceutical innovations. His role at Hybritech, a company known for its pioneering advancements in monoclonal antibodies, allows him to collaborate on groundbreaking projects aimed at addressing critical medical challenges.

Collaborations: Throughout his career, Frincke has worked alongside notable colleagues, including Barbara W Unger and Karen G Burnett. Their collective efforts have fostered an environment of collaboration and innovation, driving forward breakthroughs in biotechnology and therapeutic applications.

Conclusion: James M Frincke's contributions to the field of biotechnology exemplify the profound impact that dedicated inventors can have on healthcare. Through his innovative patents and collaborative work, Frincke continues to push the boundaries of medical science, offering new hope and enhanced treatment options for patients facing complex health issues.